| Followers | 469 |
| Posts | 30421 |
| Boards Moderated | 0 |
| Alias Born | 11/12/2016 |
Wednesday, September 04, 2019 12:01:36 AM
$CDIX DD packet updated
CEO Podcast Interview
https://twitter.com/cardifflex/status/1169044053079547905?s=21
PR on Aug 23rd gives strong indications of this LOI closing
https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
“The parties have been in confidential discussions and negotiations for several months having reached agreement in principal and are working diligently to finalize their transaction as visualized in their recently executed Letter of Intent.”
Read the underlined red lines, over & over till it sinks in that this LOI is going to close
From June 30th 10Q....
16. SUBSEQUENT EVENTS
Stock Issuances:
“In August 2019 the Company entered into a letter of intent to acquire the net assets constituting the business of Acela Biomedical, LLC, for a combination of $15 Million in Preferred Stock and $15 Million in cash. Consummation of the acquisition is conditional upon successful completion of due diligence and transfer of purchase consideration.”
Now Let me explain the current debt as shown in the filings in the last 10Q
Looking at the debt breakdown in the filing on Pages 18-19
https://www.otcmarkets.com/filing/html?id=13603658&guid=mzSIUqWlr8tIL3h
There are important aspects to realize.
1 - the older notes are friendly and have been accumulating interest for years, they are not a threat
2- some notes are due in 2021, they are not a threat
3- all new notes now have a conversion look back of only 3 days making them alot less toxic because as the pps moves up rapidly, so does the conversion rate requiring less shares to service the debt.
4- there is only active note (100k) available for conversion in August.
Also Note the company tweeted that 1 million dollars plus of its debt was serviced by May/2019
https://twitter.com/cardifflex/status/1123563346501017601?s=21
Market Cap is 1.59 million based on SS dated August 30th, 2019
https://www.otcmarkets.com/stock/CDIX/security
LOI/Acquisition is $30 mil with projected revenue of 30-90 mil
Company tweets about the LOI
Acela is a Hemp and CBD Oil producer & clinical stage biotech company growing rapidly with 138 farms currently raising over 300 acres of genetically patented Hemp which translates to $30-$90MM in future revenue.
https://twitter.com/cardifflex/status/1164941935716552706?s=21
https://twitter.com/cardifflex/status/1165440811837874176?s=21
CDIX OS and Market Cap determines PPS
https://www.otcmarkets.com/stock/CDIX/security
With our current Market Cap of 1.59 million
This LOI on the conservative side can easily justify a Market Cap of over 50 million
50/1.59 = 31.4
31.4 times yesterday’s close of .0045
Is 14 cents
Also CDIX has no business trading under a penny now as it’s Current Assets & Revenue have us above a penny
CDIX 2019 current revenue run rate is $4.4M
https://twitter.com/cardifflex/status/1123228821753344000?s=21
Interest has been phenomenal since Aug 20th (9 trading days)
https://twitter.com/keeprealistic/status/1168149421143527428?s=21
trading stats Aug 20-30th
$10,369,144 total dollars
$1,152,127 dollars per day average
1,357,502,356 total shares
150,833,595 shares per day average
That’s an avg of 1.152 million dollars per day last 9 days
LOI here is huge and company is well positioned with current SS to complete it.
$CDIX DD Cardiff Lexington Corp (CDIX) And Acela Biomedical, LLC to Merge https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
Products price $12.95 to $219.95 https://acelacbd.com/shop/
From Local Kentucky NBC Tv on Monday, Acela Biomedical utilizes clean technology to remove oil from leaves of industrial hemp plants
https://www.wlwt.com/article/cbd-products-what-you-need-to-know/28748027
Acela CBD and Ohio Department of Agriculture planting 1st legal hemp.
https://abc6onyourside.com/news/local/ohio-department-of-agriculture-plants-100-hemp-plants
Congressman Thomas Massie meeting Kentucky Farm Bureau on Aug 14th taking about legal hemp
https://www.facebook.com/RepThomasMassie/photos/pcb.2768948003129346/2768935786463901/?type=3&theater
https://www.facebook.com/RepThomasMassie/photos/pcb.2765037950187018/2765035690187244/?type=3&theater
$CDIX DD Cardiff Lexington Corp (CDIX) And Acela Biomedical, LLC to Merge https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
so in essence-- $CDIX is buying a Hemp Company with 1million plus in revenues--projected to do a billion a year in the future
CDIX's Merger Company Acela Biomedical is a legit compay.
The Acela CBD Facility is very legit
https://www.wlwt.com/article/cbd-products-what-you-need-to-know/28748027
Congressman Thomas Massie visited the Acela CBD facility in Maysville, Kentucky
12 August at 08:38 ·
I had the opportunity to tour the Acela CBD facility in Maysville, Kentucky last week. It’s always exciting to see how the new industrial hemp industry has boosted the economy in Kentucky—especially when I’m able to wear a lab coat which reminds me of my days at the Massachusetts Institute of Technology. Acela CBD is a particularly innovative startup. This company is entirely local, contracting with Kentucky farms to supply industrial hemp, honey, lemongrass, lavender, and other ingredients to use in their own products.
CEO Podcast Interview
https://twitter.com/cardifflex/status/1169044053079547905?s=21
PR on Aug 23rd gives strong indications of this LOI closing
https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
“The parties have been in confidential discussions and negotiations for several months having reached agreement in principal and are working diligently to finalize their transaction as visualized in their recently executed Letter of Intent.”
Read the underlined red lines, over & over till it sinks in that this LOI is going to close
$CDIX Cardiff Lexington Corp (CDIX) And Acela Biomedical, LLC to Mergehttps://t.co/uB3McgUSTf pic.twitter.com/CG6b13HYO6
— KIR (@KeepRealistic) September 1, 2019
From June 30th 10Q....
16. SUBSEQUENT EVENTS
Stock Issuances:
“In August 2019 the Company entered into a letter of intent to acquire the net assets constituting the business of Acela Biomedical, LLC, for a combination of $15 Million in Preferred Stock and $15 Million in cash. Consummation of the acquisition is conditional upon successful completion of due diligence and transfer of purchase consideration.”
Now Let me explain the current debt as shown in the filings in the last 10Q
Looking at the debt breakdown in the filing on Pages 18-19
https://www.otcmarkets.com/filing/html?id=13603658&guid=mzSIUqWlr8tIL3h
There are important aspects to realize.
1 - the older notes are friendly and have been accumulating interest for years, they are not a threat
2- some notes are due in 2021, they are not a threat
3- all new notes now have a conversion look back of only 3 days making them alot less toxic because as the pps moves up rapidly, so does the conversion rate requiring less shares to service the debt.
4- there is only active note (100k) available for conversion in August.
Also Note the company tweeted that 1 million dollars plus of its debt was serviced by May/2019
https://twitter.com/cardifflex/status/1123563346501017601?s=21
Market Cap is 1.59 million based on SS dated August 30th, 2019
https://www.otcmarkets.com/stock/CDIX/security
LOI/Acquisition is $30 mil with projected revenue of 30-90 mil
Company tweets about the LOI
Acela is a Hemp and CBD Oil producer & clinical stage biotech company growing rapidly with 138 farms currently raising over 300 acres of genetically patented Hemp which translates to $30-$90MM in future revenue.
https://twitter.com/cardifflex/status/1164941935716552706?s=21
https://twitter.com/cardifflex/status/1165440811837874176?s=21
CDIX OS and Market Cap determines PPS
https://www.otcmarkets.com/stock/CDIX/security
With our current Market Cap of 1.59 million
This LOI on the conservative side can easily justify a Market Cap of over 50 million
50/1.59 = 31.4
31.4 times yesterday’s close of .0045
Is 14 cents
Also CDIX has no business trading under a penny now as it’s Current Assets & Revenue have us above a penny
CDIX 2019 current revenue run rate is $4.4M
https://twitter.com/cardifflex/status/1123228821753344000?s=21
Interest has been phenomenal since Aug 20th (9 trading days)
https://twitter.com/keeprealistic/status/1168149421143527428?s=21
trading stats Aug 20-30th
$10,369,144 total dollars
$1,152,127 dollars per day average
1,357,502,356 total shares
150,833,595 shares per day average
That’s an avg of 1.152 million dollars per day last 9 days
LOI here is huge and company is well positioned with current SS to complete it.
$CDIX DD Cardiff Lexington Corp (CDIX) And Acela Biomedical, LLC to Merge https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
Products price $12.95 to $219.95 https://acelacbd.com/shop/
From Local Kentucky NBC Tv on Monday, Acela Biomedical utilizes clean technology to remove oil from leaves of industrial hemp plants
https://www.wlwt.com/article/cbd-products-what-you-need-to-know/28748027
Acela CBD and Ohio Department of Agriculture planting 1st legal hemp.
https://abc6onyourside.com/news/local/ohio-department-of-agriculture-plants-100-hemp-plants
Congressman Thomas Massie meeting Kentucky Farm Bureau on Aug 14th taking about legal hemp
https://www.facebook.com/RepThomasMassie/photos/pcb.2768948003129346/2768935786463901/?type=3&theater
https://www.facebook.com/RepThomasMassie/photos/pcb.2765037950187018/2765035690187244/?type=3&theater
$CDIX DD Cardiff Lexington Corp (CDIX) And Acela Biomedical, LLC to Merge https://www.otcmarkets.com/stock/CDIX/news/story?e&id=1422275
so in essence-- $CDIX is buying a Hemp Company with 1million plus in revenues--projected to do a billion a year in the future
CDIX's Merger Company Acela Biomedical is a legit compay.
The Acela CBD Facility is very legit
https://www.wlwt.com/article/cbd-products-what-you-need-to-know/28748027
Congressman Thomas Massie visited the Acela CBD facility in Maysville, Kentucky
12 August at 08:38 ·
I had the opportunity to tour the Acela CBD facility in Maysville, Kentucky last week. It’s always exciting to see how the new industrial hemp industry has boosted the economy in Kentucky—especially when I’m able to wear a lab coat which reminds me of my days at the Massachusetts Institute of Technology. Acela CBD is a particularly innovative startup. This company is entirely local, contracting with Kentucky farms to supply industrial hemp, honey, lemongrass, lavender, and other ingredients to use in their own products.
Recent CDIX News
- Cardiff Lexington's Nova Ortho and Spine Announces New Medical Office in Stuart, Florida to Serve the Growing Treasure Coast Community • ACCESS Newswire • 05/20/2026 12:00:00 PM
- Cardiff Lexington Announces First Quarter 2026 Financial Results • ACCESS Newswire • 05/19/2026 12:00:00 PM
- Cardiff Lexington to Report First Quarter 2026 Financial Results and Host Conference Call on Tuesday, May 19, 2026 • ACCESS Newswire • 05/14/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 05:37:38 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 05/12/2026 08:48:08 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 04/30/2026 04:53:32 PM
- Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market • ACCESS Newswire • 04/09/2026 12:00:00 PM
- OTC Markets Group Welcomes Cardiff Lexington Corporation to OTCQX • GlobeNewswire Inc. • 04/09/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 07:27:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 07:23:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 07:22:51 PM
- Cardiff Lexington Announces Fourth Quarter and Full Year 2025 Financial Results • ACCESS Newswire • 03/16/2026 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/13/2026 06:11:34 PM
- Cardiff Lexington To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Monday, March 16, 2026 • ACCESS Newswire • 03/12/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 07:06:03 PM
- Cardiff Lexington Subsidiary Nova Ortho and Spine Announces New Healthcare Hires to Support Growth • ACCESS Newswire • 02/26/2026 01:00:00 PM
- Cardiff Lexington Corporation Engages Investment Bank to Lead S-1 Filing and Nasdaq Uplist Strategy • ACCESS Newswire • 01/20/2026 01:00:00 PM
- Cardiff Lexington Announces 1-for-3 Reverse Stock Split • ACCESS Newswire • 01/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 09:00:05 PM
- Cardiff Lexington Announces Planned Retirement of Daniel Thompson as Chairman of the Board of Directors • ACCESS Newswire • 12/29/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:24:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:22:02 PM
